BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35544035)

  • 21. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
    AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
    Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide.
    Matsuno A; Murakami M; Hoya K; Yamada SM; Miyamoto S; Yamada S; Son JH; Nishido H; Ide F; Nagashima H; Sugaya M; Hirohata T; Mizutani A; Okinaga H; Ishii Y; Tahara S; Teramoto A; Osamura RY
    Med Mol Morphol; 2014 Mar; 47(1):1-7. PubMed ID: 23955641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sparsely Granulated Corticotroph Pituitary Macroadenoma Presenting With Pituitary Apoplexy Resulting in Remission of Hypercortisolism.
    Liu T; Rossiter JP; Houlden RL; Awad S
    AACE Clin Case Rep; 2022; 8(4):166-170. PubMed ID: 35959088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
    Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
    No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
    Kurowska M; Tarach JS; Malicka J; Zieliński G; Maksymowicz M; Denew P
    Endokrynol Pol; 2016; 67(5):526-533. PubMed ID: 27828691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
    Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M
    Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.
    Dillard TH; Gultekin SH; Delashaw JB; Yedinak CG; Neuwelt EA; Fleseriu M
    Pituitary; 2011 Mar; 14(1):80-91. PubMed ID: 20972839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review.
    Gilis-Januszewska A; Wilusz M; Pantofliński J; Turek-Jabrocka R; Sokołowski G; Sowa-Staszczak A; Kluczyński Ł; Pach D; Zieliński G; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2018; 69(3):306-312. PubMed ID: 29319131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained improvement in vision in a recurrent growth hormone secreting macroadenoma during treatment with octreotide in the absence of marked tumour shrinkage.
    Lindsay JR; Harding JA; Ellis PK; Sheridan B; Atkinson AB
    Pituitary; 2003; 6(4):209-14. PubMed ID: 15237932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma.
    Syro LV; Scheithauer BW; Ortiz LD; Fadul CE; Horvath E; Rotondo F; Kovacs K
    Hormones (Athens); 2009; 8(4):303-6. PubMed ID: 20045804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive Pituitary Adenomas: The Dark Side of the Moon.
    Priola SM; Esposito F; Cannavò S; Conti A; Abbritti RV; Barresi V; Baldari S; Ferraù F; Germanò A; Tomasello F; Angileri FF
    World Neurosurg; 2017 Jan; 97():140-155. PubMed ID: 27713064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.
    Paľa A; Etzrodt-Walter G; Karpel-Massler G; Pedro MT; Mayer B; Coburger J; Wirtz CR; Hlaváč M
    Neurosurg Rev; 2022 Apr; 45(2):1701-1708. PubMed ID: 34855027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series.
    Zacharia BE; Gulati AP; Bruce JN; Carminucci AS; Wardlaw SL; Siegelin M; Remotti H; Lignelli A; Fine RL
    Neurosurgery; 2014 Apr; 74(4):E447-55; discussion E455. PubMed ID: 24226425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy.
    Moshkin O; Syro LV; Scheithauer BW; Ortiz LD; Fadul CE; Uribe H; Gonzalez R; Cusimano M; Horvath E; Rotondo F; Kovacs K
    Hormones (Athens); 2011; 10(2):162-7. PubMed ID: 21724542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical Therapy of Aggressive Pituitary Tumors.
    Petersenn S
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):186-193. PubMed ID: 33690871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.
    Thearle MS; Freda PU; Bruce JN; Isaacson SR; Lee Y; Fine RL
    Pituitary; 2011 Dec; 14(4):418-24. PubMed ID: 19960369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas.
    Hlaváč M; Knoll A; Etzrodt-Walter G; Sommer F; Scheithauer M; Coburger J; Wirtz CR; Pala A
    Neurosurg Rev; 2019 Sep; 42(3):737-743. PubMed ID: 30949920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.
    Mirallas O; Filippi-Arriaga F; Hernandez Hernandez I; Aubanell A; Chaachou A; Garcia-Alvarez A; Hernando J; Martínez-Saez E; Biagetti B; Capdevila J
    Front Endocrinol (Lausanne); 2021; 12():731631. PubMed ID: 34858324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.